LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Zogenix plummets 30% after FDA refuses to review its seizure treatment
Business
April 08, 2019
This article is being updated.
Previous article: Cramer: Investors should take analyst downgrades of GE, Boeing seriously
Prev
Next article: Michael Avenatti says Nike 'pulled a stunt' by having him arrested
Next
via
CNBC
April 8th 2019
MixedTimes.com
Business
Zogenix plummets 30% after FDA refuses to review its seizure treatment
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video